This is where you will find financial information about Promore Pharma. You can download annual reports, quarterly reports and presentations and subscribe to our press releases and reports.
It is our ambition to provide the capital market, investors, shareholders and other stakeholders with relevant information to facilitate a fair valuation of the company and our external contacts. We strive to be as transparent as possible in all our actions. Do not hesitate to contact us if you require additional information.
- Promore Pharma receives delivery of hyaluronic acid from Italian manufacturer Fidia
- Interim report January – June 2021
- Invitation to Conference Call regarding Promore Pharma’s Q2 Report 2021
- The rights issue is registered and the trading in Paid Subscription Shares ceases
- Outcome in Promore Pharma’s rights issue